Serum CRP levels are known to correlate with the serum levels of several proinflammatory cytokines, such as interleukin-6 (IL-6) [10], and IL-6 has been reported to induce tumor progression via hyperactivation of the IL-6/JAK/STAT3 pathway [11]. This evidence concerns the gene IL6 and neoplasm.